Pediatrix Q2 adjusted EPS $0.47 vs $0.41 YoY; revenue up 2.7%; FY22 EBITDA outlook reaffirmed

Pediatrix Medical Group, Inc.

2022-Q2 EPS reported $0.07 revenue$968,262,000

GAAP EPS $0.36 flat YoY; adjusted EPS $0.47 vs $0.41 on revenue of $486M (+2.7%).
Same-unit revenue down 1.3%; volume up 0.6% offset by reimbursement decline of 1.9%.
Adjusted EBITDA flat at $65.6M; FY22 outlook reaffirmed at $260-270M.
Repurchased 3.3M shares for $64.4M in Q2; total debt $800M after refinancing.
Interest expense fell to $8.4M from $16.9M due to Q1 refinancing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.